Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Royal Medical Center vs NovoCare Pharmacy

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

5.1

Royal Medical Center

Best for Buyers who prioritize a named, credentialed MD founder (Dr. Dagoberto Rodriguez, Emory-trained, 30+ years of practice) and an itemized dose-strength pricing ladder over the lowest-possible monthly cost. Fit for buyers who already need HRT/TRT or a broad peptide adjunct stack and want to consolidate GLP-1 + hormone + peptide programs under one clinic. NOT for buyers who want semaglutide, oral/ODT/troche formats, the lowest cash-pay price (Trimi $99, Coby $99/$179, AVARA $229/$279, Trava are all cheaper), explicit state availability, a named pharmacy partner, a LegitScript badge, or a written refund policy.
★★★☆☆2.6

Starting at $450/mo

Compounded tirzepatide injection — 4-tier monthly ladder $450 / $650 / $800 / $1,100All-inclusive pricing: medication, supplies, injections, lab monitoring, physician consultations, follow-upsNamed MD founder: Dr. Dagoberto Rodriguez (Emory residency, former chairman Coral Springs Medical Center, U Miami teaching faculty)Comprehensive HRT/TRT catalog (testosterone $89 first-month promo, estrogen/progesterone, HCG, enclomiphene)
Visit Royal Medical Center →
8.7

NovoCare Pharmacy

Best for branded Wegovy at the lowest manufacturer-direct self-pay price
★★★★☆4.4

Starting at $199/mo

WegovyBrandManufacturer DirectAll 50 States
Visit NovoCare Pharmacy →

Side-by-Side Comparison

FeatureRoyal Medical CenterNovoCare Pharmacy
Overall Score5.1/10✓8.7/10
Starting Price$450/mo✓$199/mo
Editorial Rating2.6 ★ /5✓4.4 ★ /5
Features✓10 features5 features
States Available0✓50
Compounded——
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA WarningsNoneNone

Pros & Cons

Royal Medical Center

Pros

  • ✓Strong, verifiable physician founder: Dr. Dagoberto Rodriguez M.D. — Emory University residency, former chairman of Coral Springs Medical Center (1997-2000), Blue Cross Blue Shield peer review committee member, University of Miami School of Medicine teaching faculty since 2004. Unusually strong credentialing vs typical DTC compounded-GLP-1 storefronts.
  • ✓Tirzepatide pricing is fully itemized by dose-strength tier ($450 / $650 / $800 / $1,100) — significantly more transparent than the 'starting at $X' floor common to DTC peers (Trimi, Coby, AVARA Rx all advertise floors only).
  • ✓All-inclusive pricing claim: medication + supplies + injections + lab monitoring + physician consultations + follow-ups bundled at the monthly tier rate (verbatim from /weight-loss/ page).
  • ✓Broad adjunct catalog (HRT, TRT, peptides, ED, hair, vitamins) suggests an established multi-program clinic vs single-product GLP-1 startup.
  • ✓Florida physician footprint + 30+ years of practice history is a positive E-E-A-T signal for buyers prioritizing physician-led care.

Cons

  • ✗Operating legal entity / LLC suffix NOT disclosed verbatim on the homepage, about page, or contact page — only 'Royal Medical Center' brand surfaced.
  • ✗Pharmacy partner NOT named — only generic 'US-based Pharmacy' language on the tirzepatide product page and 'discreetly shipped from the pharmacy' on the homepage. Buyers cannot independently verify the dispensing pharmacy's licensure or 503A/503B status.
  • ✗LegitScript verification badge NOT displayed on the homepage, weight-loss page, or product pages (none of the audited pages surfaced a LegitScript seal).
  • ✗State availability NOT enumerated — site says 'nationwide' but provides no 50-state list or state-restriction notice. The presence of a California-only SKU (hair regrowth) suggests at least some state-specific compliance handling that is not surfaced for the GLP-1 program.
  • ✗Cloudflare challenge wall (HTTP 403 to non-browser User-Agents) prevented direct live verification; this audit relied on a Wayback Machine snapshot from Oct 16 2025, so the data may not reflect the current site state.
  • ✗Headline 'starting at $116/mo' for weight loss is inconsistent with the actual tirzepatide product page floor of $450/mo — the $116 figure likely refers to a different program (possibly testosterone or hormone therapy) and may mislead GLP-1 shoppers.
  • ✗Semaglutide NOT offered for weight loss — tirzepatide-only. Buyers wanting a sema option (cheaper at most DTC peers) must look elsewhere.
  • ✗No semaglutide, no Wegovy, no Zepbound, no Foundayo, no oral/ODT/troche formats — injection-only, single-molecule.
  • ✗Refund / cancellation policy NOT surfaced on the homepage, weight-loss page, or product page.
  • ✗Insurance acceptance NOT addressed — cash-pay model implied but not stated.
  • ✗Lab work requirement: lab monitoring is bundled into the all-inclusive program, but it is unclear whether baseline labs are required before the first shipment or can be drawn after starting therapy.
  • ✗BBB profile NOT found (BBB search for 'royal medical centers' returned zero results as of 2026-05-28).
  • ✗Pricing is mid-to-high tier ($450 floor for tirz) vs the lowest-cost DTC compounded-tirz market ($179-$279 floor at Coby, Trava, AVARA Rx, Trimi).

NovoCare Pharmacy

Pros

  • ✓First-party manufacturer pharmacy — the most authoritative branded Wegovy channel possible
  • ✓$199/month intro pricing for Wegovy 0.25 mg and 0.5 mg starter doses (through 6/30/2026) is the lowest brand-name self-pay price for the FDA-approved Wegovy product
  • ✓$349/month standard self-pay for full-dose Wegovy is well below the ~$1,300/month list price at retail pharmacies
  • ✓Ships to all 50 states; no telehealth-platform middleman fees
  • ✓Cold-chain logistics handled by Novo Nordisk directly — no risk of mishandling between manufacturer and patient
  • ✓Insurance-billing path also available via the standard NovoCare savings program

Cons

  • ✗Wegovy only — no semaglutide for type 2 diabetes (Ozempic), no compounded GLP-1, no tirzepatide
  • ✗Requires an existing valid Wegovy prescription — NovoCare Pharmacy does not employ prescribing clinicians or operate a telehealth intake. You need a separate visit (PCP, endocrinologist, or another telehealth provider) to get the script first
  • ✗$199 intro pricing is dose-restricted (0.25 mg / 0.5 mg only) and time-limited (through 6/30/2026) — most patients on the maintenance 1.7 / 2.4 mg dose pay $349/month
  • ✗No clinical support included with the pharmacy fulfillment — your prescribing clinician handles titration and side-effect monitoring
  • ✗Manufacturer-set pricing can change at any time

Our Verdict

Winner: NovoCare PharmacyScore: 8.7/10

NovoCare Pharmacy edges out Royal Medical Center with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. Royal Medical Center remains a solid alternative, especially if you're looking for Buyers who prioritize a named, credentialed MD founder (Dr. Dagoberto Rodriguez, Emory-trained, 30+ years of practice) and an itemized dose-strength pricing ladder over the lowest-possible monthly cost. Fit for buyers who already need HRT/TRT or a broad peptide adjunct stack and want to consolidate GLP-1 + hormone + peptide programs under one clinic. NOT for buyers who want semaglutide, oral/ODT/troche formats, the lowest cash-pay price (Trimi $99, Coby $99/$179, AVARA $229/$279, Trava are all cheaper), explicit state availability, a named pharmacy partner, a LegitScript badge, or a written refund policy..

Get Started with Royal Medical Center →Get Started with NovoCare Pharmacy →

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring Royal Medical Center and NovoCare Pharmacy head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.